CLINICAL_TRIALS
trial_result
· 2018-07-31
Clinical Trial Update: Accuracy of Markerless Motion Capture Evaluation in Parkinson's Disease After DBS [NA]
Summary
The study completed an evaluation of markerless motion capture for assessing movement in Parkinson disease patients after deep brain stimulation.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Hospital Zambrano Hellion | Conditions: Parkinson Disease | NA | Status: COMPLETED